Henzl MR
No ORCID on file
· 13 papers in corpus
· active 1977-1998
Study types
- article 9
- review 3
- other 1
Condition tags
- endometriosis 12
- chronic_pelvic_pain 2
- dysmenorrhea 1
Top journals
Frequent coauthors
- Milan R. Henzl 12
- Jan J. Jacobson 2
- Kwei L 2
- Long Kwei 2
- Bergquist C 2
- W L Heinrichs 2
- Heinrichs WL 2
- Buttram VC 1
- Alison Edelman 1
- C Hamrang 1
article
1998
OBJECTIVE: To project the efficacy and economic consequence of short-term intranasal gonadotropin-releasing hormone agonist (GnRH-a) for diagnosis of and therapy for endometriosis. STUDY DESIGN: Multicenter, placebo-controlled clinical tria…
article
1998
OBJECTIVE: To draw attention to the structural features of adhesions associated with pelvic endometriosis since they are less well studied than endometriosis proper. STUDY DESIGN: Sixty-two samples of periovarian adhesions were laparoscopic…
other
1998
article
1997
OBJECTIVE: To compare intranasal nafarelin and intramuscular leuprolide acetate (LA) depot in the management of endometriosis. STUDY DESIGN: A multicenter, prospective, randomized, double-placebo, double-blind study was conducted on subject…
article
1997
ObjectiveOur goal was to determine the effects of a repeated course of the gonadotropin-releasing hormone agonist nafarelin on symptoms and signs of endometriosis and lumbar and distal radius bone mineral density.Study designForty-five wome…
review
1993
review
1992
Clinical trials are under way to investigate the optimal use of nafarelin. In one series of studies, the effect of nasal mucosal inflammation and the concomitant use of nasal decongestants on the nasal absorption of nafarelin was evaluated …
article
1990
The efficacy and safety of the gonadotropin-releasing hormone agonist nafarelin for treatment of endometriosis were compared with those of danazol in two large-scale, double-blind trials. Assessments of severity of symptoms, laparoscopic sc…
article
1990
article
1989
A large, multicenter, double-blind clinical trial established that the gonadotropin releasing hormone analog nafarelin relieves clinical symptoms, decreases laparoscopic scores and improves fertility in women with endometriosis. Side effect…
article
1988
Treatment with nafarelin, a gonadotropin-releasing hormone agonist, reversibly inhibits ovarian function and induces hypoestrogenemia. To determine the efficacy of such hormonal manipulation in the treatment of endometriosis, we randomly as…
review
1988
article
1977
Clinical findings suggest a relationship between prostaglandins of the F2a group progesterone and dysmenorrhea. The menstrual flow of 5 dysmenorrhoic women aged 20-30 years was collected 2 cycles with and 2 cycles without local intrauterine…